SecBot SecBot

SHC

Sotera Health Co
Nasdaq· Services-Misc Health & Allied Services, NEC· Inc. DE· CIK 0001822479 Healthcare & Medical Devices
$16.61 +0.31 (+1.90%)
Nov 13 4:00 PM ET · prev $16.30
Market cap
$4.7B
Mid cap
Consensus
Buy
80% Buy or better · 15 analysts
Median target
$22.00
+32% · range $15.00–25.00
1 year
+8.8%
from $15.26 · Nov 17
30 days
−5.8%
from $17.64
52-week range
$13.13–19.57
−15% from high · low Mar 27
Avg volume 20D
2.70M
shares / day
Short interest
16.44M
≈5.8% of shares · +2.1%
Days to cover
7.5
at average volume
Insider net
−$1.4B
0 buyers · 4 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 2 exits
Filing reports
18
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 1 bearish · 1 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 4/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $1.4B.

  • InstitutionsBULLISH

    Q3 2026: 38 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    12 of 15 rate it Buy or better. Median target $22.00 (+32%).

  • Short sellersSTEADY

    Short interest +2.1% to 16.44M shares. 7.5 days to cover, ≈5.8% of shares.

  • TrendDOWNTREND

    8% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
2
exits
FundMoveSharesValue
JPMORGAN CHASE & CODOUBLED2,506,745$46.9M
Bank of New York Mellon CorpADD1,987,882$36.8M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED1,512,879$28.0M
Nuveen, LLCDOUBLED1,468,232$27.1M
LOS ANGELES CAPITAL MANAGEMENT LLCDOUBLED1,293,965$23.9M
BARCLAYS PLCDOUBLED550,275$10.2M
SEI INVESTMENTS CODOUBLED416,507$7.7M
Quantinno Capital Management LPADD334,006$6.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 80% rate it Buy or better
Strong Buy5Buy7Hold2Sell1Strong Sell0
12-month targets · 9 analysts

Price is inside the target range. Median implies +32%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 4, 2026JP Morgan
MAINTAIN
MAINTAINUnderweight
Nov 4, 2026Barclays
MAINTAIN
MAINTAINOverweight
Oct 14, 2026JP Morgan
DOWNGRADE
DOWNGRADEUnderweight
Aug 7, 2026Citigroup
MAINTAIN
MAINTAINBuy
Aug 7, 2026Barclays
MAINTAIN
MAINTAINOverweight
Aug 7, 2026Piper Sandler
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$1.4B
sold · 4 insiders
DateInsiderTypeValue
Aug 17, 2026
Petras Michael B. Jr.
Executive Chairman
Aug 17, 2026
SELL$15.7M
Aug 17, 2026
Petras Michael B. Jr.
Executive Chairman
Aug 17, 2026
SELL$5.4M
Aug 7, 2026
Rutz Michael P
President of Sterigenics
Aug 7, 2026
SELL$2.8M
Aug 5, 2026
Lyons Jonathan M.
Sr. Vice President, CFO
Aug 5, 2026
TAX W/H$203.5K
May 26, 2026
SHADER ALTON
Chief Executive Officer
May 26, 2026
AWARD375,939 sh
May 26, 2026
SHADER ALTON
Chief Executive Officer
May 26, 2026
AWARD203,634 sh
May 26, 2026
SHADER ALTON
Chief Executive Officer
May 26, 2026
AWARD101,817 sh
May 22, 2026
Wheadon David E.
Director
May 22, 2026
AWARD14,970 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
16,439,623
shares short
+2.1%
vs prior settlement
7.5
days to cover
≈5.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 3, 2026 SEC
Sotera Health reported Q3 2026 net revenues of $324.9M, up 4.4% YoY, and Adjusted EPS of $0.29, a 12% increase. The…
8-K · Impact 5/10
Nov 3, 2026 SEC
Sotera Health reported Q3 2026 adjusted EPS of $0.29, beating the $0.27 consensus by 7.4%, and revenue of $324.9M…
PRESS-RELEASE · Impact 5/10
Nov 3, 2026 Earnings
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Oct 30, 2026 SEC
Vanguard Capital Management LLC filed a Schedule 13G disclosing a 5.12% passive stake in Sotera Health Co as of…
SC 13G · Impact 3/10
Sep 30, 2026 Inst.
JPMORGAN CHASE & CO · DOUBLED
2,506,745 shares ($46.9M)
Sep 30, 2026 Inst.
Bank of New York · ADD
1,987,882 shares ($36.8M)
Aug 17, 2026 Insider
Petras Michael B. Jr. sold 850,000 shares
Executive Chairman @ $18.50 ($15.7M)
Aug 17, 2026 Insider
Petras Michael B. Jr. sold 294,515 shares
Executive Chairman @ $18.50 ($5.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

18 filings · 5 bullish · 4 bearish · 9 neutral
All SHC filing & press-release reports (18)